» Articles » PMID: 18545679

Gremlin Enhances the Determined Path to Cardiomyogenesis

Overview
Journal PLoS One
Date 2008 Jun 12
PMID 18545679
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The critical event in heart formation is commitment of mesodermal cells to a cardiomyogenic fate, and cardiac fate determination is regulated by a series of cytokines. Bone morphogenetic proteins (BMPs) and fibroblast growth factors have been shown to be involved in this process, however additional factors needs to be identified for the fate determination, especially at the early stage of cardiomyogenic development.

Methodology/principal Findings: Global gene expression analysis using a series of human cells with a cardiomyogenic potential suggested Gremlin (Grem1) is a candidate gene responsible for in vitro cardiomyogenic differentiation. Grem1, a known BMP antagonist, enhanced DMSO-induced cardiomyogenesis of P19CL6 embryonal carcinoma cells (CL6 cells) 10-35 fold in an area of beating differentiated cardiomyocytes. The Grem1 action was most effective at the early differentiation stage when CL6 cells were destined to cardiomyogenesis, and was mediated through inhibition of BMP2. Furthermore, BMP2 inhibited Wnt/beta-catenin signaling that promoted CL6 cardiomyogenesis.

Conclusions/significance: Grem1 enhances the determined path to cardiomyogenesis in a stage-specific manner, and inhibition of the BMP signaling pathway is involved in initial determination of Grem1-promoted cardiomyogenesis. Our results shed new light on renewal of the cardiovascular system using Grem1 in human.

Citing Articles

Expression of Osteopontin and Gremlin 1 Proteins in Cardiomyocytes in Ischemic Heart Failure.

Kupryte M, Lesauskaite V, Sirataviciute V, Utkiene L, Jusiene L, Pangonyte D Int J Mol Sci. 2024; 25(15).

PMID: 39125809 PMC: 11311846. DOI: 10.3390/ijms25158240.


Progress in preclinical research on induced pluripotent stem cell therapy for acute myocardial infarction.

Cai S, Dai Q Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(2):244-253.

PMID: 38594961 PMC: 11057988. DOI: 10.3724/zdxbyxb-2023-0402.


Overexpression of GREM1 Improves the Survival Capacity of Aged Cardiac Mesenchymal Progenitor Cells via Upregulation of the ERK/NRF2-Associated Antioxidant Signal Pathway.

Kaur G, Wang X, Li X, Ong H, He X, Cai C Cells. 2023; 12(8).

PMID: 37190112 PMC: 10136744. DOI: 10.3390/cells12081203.


The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.

Wruck W, Bremmer F, Kotthoff M, Fichtner A, Skowron M, Schonberger S J Cell Mol Med. 2021; 25(3):1394-1405.

PMID: 33448076 PMC: 7875904. DOI: 10.1111/jcmm.16222.


miR-21 is upregulated, promoting fibrosis and blocking G2/M in irradiated rat cardiac fibroblasts.

Guo H, Zhao X, Su H, Ma C, Liu K, Kong S PeerJ. 2020; 8:e10502.

PMID: 33354435 PMC: 7733651. DOI: 10.7717/peerj.10502.


References
1.
Gavert N, Ben-Zeev A . beta-Catenin signaling in biological control and cancer. J Cell Biochem. 2007; 102(4):820-8. DOI: 10.1002/jcb.21505. View

2.
Reifers F, Walsh E, Leger S, Stainier D, Brand M . Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar). Development. 1999; 127(2):225-35. DOI: 10.1242/dev.127.2.225. View

3.
Schneider V, Mercola M . Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev. 2001; 15(3):304-15. PMC: 312618. DOI: 10.1101/gad.855601. View

4.
Hamatani T, Carter M, Sharov A, Ko M . Dynamics of global gene expression changes during mouse preimplantation development. Dev Cell. 2004; 6(1):117-31. DOI: 10.1016/s1534-5807(03)00373-3. View

5.
Whitehead G, Makino S, Lien C, Keating M . fgf20 is essential for initiating zebrafish fin regeneration. Science. 2005; 310(5756):1957-60. DOI: 10.1126/science.1117637. View